Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma #MMPMID19760951
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology 2009[Jul]; 56 (93): 1105-10 PMID19760951show ga
BACKGROUND/AIMS: The purpose of this study was to examine the roles of tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, IL-18, and alpha-fetoprotein (AFP) in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC). METHODOLOGY: AFP and cytokine serum concentrations were determined via EIA or ELISA. RESULTS: In total, 81 patients were included, including 9 healthy controls, 36 LC patients, and 36 HCC patients. Significant differences in AFP, TNF-alpha, IL-6, and IL-18 between the three groups were noted (p < 0.001). AFP was lowest in the healthy subjects, intermediate in LC patients and highest in HCC patients (all p < 0.001). 11-6 and 11-18 concentrations were significantly higher in the HCC group than the other two groups. HCC and LC patients with AFP concentration > 7ng/ml had increased IL-18 concentrations compared to both the other groups p < 0.001). In contrast to previously published studies, TNF-alpha was highest in the healthy group, intermediate in the HCC group, and lowest in the LC group (p < 0.001). CONCLUSIONS: IL-18 may be a potential tumour marker in combination with IL-6 and AFP in the diagnosis of HCC, but further research including a larger population of patients is essential. Further research is warranted.
Hepatogastroenterology 2009 ; 56 (93): 1105-10
